Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases
Rev. Soc. Bras. Med. Trop
;
46(4): 525-527, Jul-Aug/2013. tab
Article
in English
| LILACS
| ID: lil-683332
ABSTRACT
Artemisinin-based combination therapy-resistant malaria is rare in Sub-Saharan Africa. The World Health Organization identifies monitoring and surveillance using day-3 parasitaemia post-treatment as the standard test for identifying suspected artemisinin resistance. We report three cases of early treatment failure due to possible artemisinin-based combination therapy-resistant Plasmodium falciparum malaria. All cases showed adequate clinical and parasitological responses to quinine. This study reveals a need to re-evaluate the quality and efficacy of artemisinin-based combination therapy agents in Nigeria and Sub-Saharan Africa.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Quinine
/
Malaria, Falciparum
/
Artemisinins
/
Antimalarials
Type of study:
Prognostic study
Limits:
Adult
/
Female
/
Humans
Country/Region as subject:
Africa
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2013
Type:
Article
Affiliation country:
Nigeria
Institution/Affiliation country:
Federal Teaching Hospital Abakaliki/NG
Similar
MEDLINE
...
LILACS
LIS